John M. Fluke's Insider Trades & SAST Disclosures
John M. Fluke's most recent trade in Athira Pharma Inc was a trade of 20,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 24, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John M. Fluke.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Athira Pharma Inc | John M. Fluke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Athira Pharma Inc | John M. Fluke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Athira Pharma Inc | John M. Fluke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 13,871 | 13,871 | - | - | Stock Option (Right to Buy) | |
| Athira Pharma Inc | John M. Fluke | Director | Other type of transaction at price $ 0.00 per share. | 15 Jun 2021 | 3,000 | 3,731 | - | 0 | Common Stock | |
| Athira Pharma Inc | John M. Fluke | Director | Other type of transaction at price $ 0.00 per share. | 15 Jun 2021 | 1,000 | 144,884 | - | 0 | Common Stock | |
| Athira Pharma Inc | John M. Fluke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 13,871 | 13,871 | - | - | Stock Option (Right to Buy) | |
| Athira Pharma Inc | John M. Fluke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 25,220 | 0 | - | - | Stock Option (Right to Buy) | |
| Athira Pharma Inc | John M. Fluke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 03 Feb 2021 | 25,220 | 140,101 | - | 1.2 | 30,012 | Common Stock |
| Athira Pharma Inc | John M. Fluke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.35 per share. | 03 Feb 2021 | 3,783 | 143,884 | - | 1.3 | 5,107 | Common Stock |
| Athira Pharma Inc | John M. Fluke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 3,783 | 0 | - | - | Stock Option (Right to Buy) | |
| Athira Pharma Inc | John M. Fluke | Director | 22 Sep 2020 | 51,831 | 0 | - | - | Series A-1 Preferred Stock | ||
| Athira Pharma Inc | John M. Fluke | Director | 22 Sep 2020 | 51,831 | 114,881 | - | 0 | Common Stock | ||
| Athira Pharma Inc | John M. Fluke | Director | 22 Sep 2020 | 12,610 | 0 | - | - | Series A Preferred Stock | ||
| Athira Pharma Inc | John M. Fluke | Director | 22 Sep 2020 | 12,610 | 63,050 | - | 0 | Common Stock | ||
| Athira Pharma Inc | John M. Fluke | Director | 22 Sep 2020 | 6,731 | 0 | - | - | Series B-1 Preferred Stock | ||
| Athira Pharma Inc | John M. Fluke | Director | 22 Sep 2020 | 6,731 | 6,731 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges